Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Multi-Center Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have An Inadequate Response to Current Non-Biologic DMARD or Anti-TNF Therapy Roche Completed Tocilzumab 3b MA21573 KFSH & RC-J
Multicenter Inetrnational neoadjuvant randomized double-blind trial comparing fulvestrant to a combination of fulvestrant and palcociclib in patients with operable luminal breast cancer responding to fulvestrant ICR Group - International Cancer Research group Ongoing palbociclib fulvestrant 3 ICRG 1201 KKUH
"Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients with Sickle Cell Disease or Other Anemias" ApoPharma Ongoing Deferiprone 3b LA38-EXT ACH
Lessening Organ Dysfunction with VITamin C KAIMRC Completed ascorbic acid injection 3 CT19/022/R King Abdulaziz Medical City NG (Riyadh)
Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients: Prospective Randomized Control trial King Fahad Hospital of the University Completed Ketamine 3 2016-01-042 -Version 02 KFUH
Intra Peritoneal Instillation of Ropivacaine with or without Dexmedetomidine for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy. A randomized controlled King Abdullah Medical City, Makkah Completed Dexmedetomidine 2 version 4 KAMC
Intra Peritoneal Instillation of Ropivacaine with or without Dexmedetomidine for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy. A randomized controlled King Abdullah Medical City, Makkah Completed Dexmedetomidine 2 version 4 KAMC
International, randomized, open label study to compare the safety and efficacy of lixisenatide vs sulfonylurea on top of basal insulin treatment in Type 2 Diabetes Mellitus subjects who elect to fast during Ramadan Sanofi Terminated Lixisenatide 3 LPS14410 KKUH
Inflammatory Regulation Effect of NAC on COVID-19 Treatment KKUH Ongoing N-acetylcysteine 3 E-20-4934 King Khalid University Hospital (Riyadh)
Inflammatory Regulation Effect of NAC on COVID-19 Treatment KKUH Ongoing N-acetylcysteine 3 E-20-4934 King Khalid University Hospital (Riyadh)
View 301 - 310 From 816